AEON Biopharma Inc Class A

Financials

Cash from operating activities -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -17.31 M Cash from investing activities -276 M401.93 K-306 K—-4 000 -4 000 Cash from financing activities 277.99 M150 K40.51 M15.15 M20.3 M 20.3 M Free cash flow -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -17.31 M

Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.

AEON

Financials

AEON Biopharma Inc Class A

Nouvelles

AEON Biopharma annonce des progrès sur son biosimilaire et sécurise un financement

AEON Biopharma nomme John Bencich au poste de directeur financier

AEON Biopharma names John Bencich as chief financial officer

L’action d’Aeon Biopharma chute après une réunion avec la FDA et une restructuration de dette

Aeon Biopharma stock falls after FDA meeting and debt restructuring

AEON Biopharma termine sa réunion avec la FDA, les actionnaires approuvent les transactions

AEON Biopharma completes FDA meeting, shareholders approve transactions

AEON et Daewoong finalisent un accord d’échange dette-actions de 15 millions $

AEON and Daewoong finalize $15 million debt-to-equity exchange deal

Ocado’s robotic future under threat as Kroger looks to Instacart

AEON Biopharma schedules FDA meeting to review botox biosimilar data

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711